Kathleen Dorritie
University of Pittsburgh(US)UPMC Health System(US)UPMC Hillman Cancer Center(US)University of Pittsburgh Medical Center(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Lymphoma Diagnosis and Treatment, Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research
Most-Cited Works
- → Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma(2023)373 cited
- → Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1–2 study(2023)182 cited
- → Phase 1 clinical trial of adoptive immunotherapy using “off-the-shelf” activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia(2017)173 cited
- → Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium(2023)161 cited
- → Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel in patients with relapsed/refractory CLL or SLL(2021)118 cited
- → Outcomes of Patients with Large B-cell Lymphoma Progressing after Axicabtagene Ciloleucel(2020)93 cited